Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL245934 | 0.97 | — | — | |
| Alcohol SCHEMBL28844459 | 0.94 | TSHR (0.41) | — | |
| Butane SCHEMBL3800696 | 0.93 | TSHR (0.45) | — | |
| Ethane SCHEMBL3206765 | 0.93 | — | — | |
| Water SCHEMBL27261424 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL5354584 | 0.90 | — | — | |
| SCHEMBL4941414 | 0.90 | TSHR (0.43) | — | |
| Hydrochloric Acid SCHEMBL4397271 | 0.88 | — | — | |
| Benzene SCHEMBL5799578 | 0.88 | ALOX15 (0.42) | — | |
| Hydrochloric Acid SCHEMBL5591468 | 0.88 | EPHX1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115960020-B | Caffeic acid nitrone compound and preparation method and application thereof | 深圳枫语生物医药科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-110330489-B | Quinolone thiazole oxime compound and preparation method and application thereof | 西南大学 | 2023-11-21 | — | — | CN | claimed |
| CN-103479602-A | Application of hydroxylamine derivatives in neural degenerative disorder treatment | LI WEIYONG | 2014-01-01 | — | — | CN | claimed |
| CN-101851176-A | Novel nitrone ligand, organic metal iridium catalyst and preparation method and application thereof | SUZHOU SINOCOMPOUND TECHNOLOGY CO LTD | 2010-10-06 | — | — | CN | claimed |
| CN-1263735-C | Process for preparation of alpha-(2,4-disulfophenyl)-N-tert-butylnitrone and pharmaceutically acceptable salts thereof | ASTRAZENECA AB (SE) | 2006-07-12 | — | — | CN | claimed |
| CN-1394200-A | Process for preparation of alpha-(2,4-disulfophenyl)-N-tert-butylnitrone and pharmaceutically acceptable salts thereof | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | CN | claimed |
| CN-122036557-A | Cycloserine intermediate and application thereof | 山东潍坊润丰化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4703355-A1 | FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME | Unimatec Co., Ltd. (JP) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024225214-A1 | FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME | ユニマテック株式会社 | 2024-10-31 | — | — | WO | disclosed |
| CN-115960020-B | Caffeic acid nitrone compound and preparation method and application thereof | 深圳枫语生物医药科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117126118-A | Synthesis method of celecoxib | 上海应用技术大学 | 2023-11-28 | — | — | CN | disclosed |
| EP-4210738-A2 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023122772-A1 | OXIME DERIVATIVES USEFUL AS T CELL ACTIVATORS | GOSSAMER BIO SERVICES, INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-1994014058-A1 | CONTROL REAGENT CONTAINING A HYDROXYLAMINE OR AN ANTIOXIDANT | BOEHRINGER MANNHEIM CORPORATION (US) | 1994-06-23 | — | — | WO | disclosed |
| EP-0581613-A1 | Process for preparing N,O-dialkylhydroxycarbamic acid esters | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-02-02 | — | — | EP | disclosed |
| CN-1019492-B | Process for preparing benzo-and thiazolo-imidazodiazepine * derivatives | HOFFMANN LA ROCHE (CH) | 1992-12-16 | — | — | CN | disclosed |
| CN-85101490-A | IMIDAZODIAZEPINE DERIVATIVES | — | 1987-01-24 | — | — | CN | disclosed |
| EP-0126088-A1 | ARYL SUBSTITUTED 7-OXABICYCLOHEPTANE COMPOUNDS | E.R. SQUIBB & SONS, INC. (US) | 1984-11-28 | — | — | EP | disclosed |
| US-4463015-A | Aryl substituted 7-oxabicycloheptane compounds, useful in inhibiting platelet aggregation | E. R. SQUIBB & SONS, INC. (US) | 1984-07-31 | — | — | US | disclosed |
| WO-1984000754-A1 | ARYL SUBSTITUTED 7-OXABICYCLOHEPTANE COMPOUNDS | SQUIBB & SONS INC (US) | 1984-03-01 | — | — | WO | disclosed |